Herbalife Nutrition Achieves Net Sales Growth of 15% in the Third Quarter, Establishes New $1.5 Billion Share Repurchase Program, Provides Initial Full Year 2019 Guidance LOS ANGELES--(BUSINESS WIRE)

Nutrition Achieves Net Sales Growth of 15% in the Third Quarter,

Establishes New $1.5 Billion Share Repurchase Program, Provides Initial

Full Year 2019 Guidance

LOS ANGELES--(BUSINESS WIRE)--October 30, 2018--Herbalife Nutrition Ltd.

(NYSE: HLF) today reported financial results for the third quarter ended

"Our strong sales and earnings performance during the third quarter

demonstrate the global consumer demand for our nutrition products," said

Rich Goudis, CEO of Herbalife Nutrition.

Reported net sales of $1.2 billion increased 15% compared to third

Volume points of 1.5 billion, increased 15% compared to the prior year

period, above the guidance range of 8.5%- 12.5%. This was the largest

year over year volume point percentage growth in a single quarter

Reported diluted EPS of $0.49 and adjusted1 earnings of

$0.74 per adjusted2 diluted share, compared to $0.33 and

$0.41, respectively, for the third quarter last year, which were

negatively impacted by expenses of approximately $4.4 million or $0.02

per share related to the China Growth and Impact Investment Program.

Updating FY 2018 volume point and net sales guidance range to 8.6% -

9.6% growth and 9.9% - 10.9% growth, respectively, as well as reported

and adjusted1 diluted EPS guidance to $1.99 - $2.09 and

$2.74 - $2.84, respectively.

Initiating FY 2019 net sales guidance in a range of 2.8% - 6.8%

growth, which includes an approximate 220 bps currency headwind.

Company announces board approval of a new five year $1.5 billion share

Third Quarter 2018 Key Metrics3

Regional Volume Point Metrics

_____________________

1 Adjusted diluted EPS is a non-GAAP measure and, for the

purpose of guidance, excludes the impact of: non-cash interest expense

associated with the Company's convertible notes, expenses related to

regulatory inquiries, China grant income, contingent value rights

revaluation, loss on extinguishment of convertible debt, loss on

extinguishment of the Company's 2017 senior secured credit facility, and

Venezuela currency devaluation. Adjusted diluted EPS, for the purpose of

reported results, excludes the impact of the foregoing as well as

expenses relating to challenges to the Company's business model, and

expenses relating to FTC Consent Order implementation. See Schedule A -

"Reconciliation of Non-GAAP Financial Measures" for a detailed

reconciliation of adjusted net income to net income calculated in

accordance with GAAP and a reconciliation of adjusted diluted EPS to

diluted EPS calculated in accordance with GAAP and a discussion of why

we believe these non-GAAP measures are useful.

Schedule A - "Reconciliation of Non-GAAP Financial Measures" for a

reconciliation of adjusted diluted share count to reported diluted share

count and a discussion of why the share count has been adjusted for

purposes of calculating adjusted diluted EPS for the third quarter of

3 Supplemental tables that include Average Active

Sales Leader and additional business metrics can be found at http://ir.Herbalife.com.

(a) During 2018, the Company adjusted volume point values for

certain products in Mexico, North America and South & Central America.

Excluding these adjustments, the worldwide total year over year change

in volume points would have been an increase of 14.3%.

Regional Net Sales and Foreign Exchange ("FX") Impact

(a) Venezuela was impacted by significant price increases and

erosion in foreign currency exchange rates. Venezuela represents less

than 1% of the Company's consolidated net sales. See Schedule A -

"Reconciliation of Non-GAAP Financial Measures" for a discussion of why

we believe adjusting for Venezuela is useful.

Following is the Company's fourth quarter 2018, full year 2018 and full

year 2019 guidance based on current business trends:

(a) We are evaluating our current approach to assigning and

maintaining volume point values for certain products or markets.

Guidance excludes any future potential impact of volume point

adjustments, which may have an impact on the use of volume points as a

proxy for sales trends in future periods.

future potential Venezuela currency devaluations and associated pricing

and inflationary consequences.

(c) Excludes the following

items that cannot be accurately predicted: any future potential ongoing

tax effects from the exercise of equity awards that could impact the

Company's tax rate due to the updated stock compensation accounting

standard, any future contingent value rights revaluation, benefits from

future potential China grant income, any future potential dilution from

the Company's convertible notes due in 2019 and 2024, as well as any

impact of the China Growth and Impact Investment Program.

Adjusted1 diluted EPS and adjusted effective tax rate

excludes the impact of: non-cash interest expense associated with the

Company's convertible notes, expenses related to regulatory inquiries,

China grant income, contingent value rights revaluation, loss on

extinguishment of convertible debt, loss on extinguishment of the

Company's 2017 senior secured credit facility and Venezuela currency

devaluation, as detailed in Schedule A. See Schedule A - "Reconciliation

of Non-GAAP Financial Measures" for a detailed reconciliation of

adjusted diluted EPS to diluted EPS calculated in accordance with GAAP

and a discussion of why the Company believe these non-GAAP measures are

(e) Currency adjusted net sales and adjusted diluted EPS

represent projections translated into US dollars at currency rates equal

to the average rates used to translate 2018 full year net sales and

diluted EPS guidance and adjusted for items such as hedging gains/losses

and Venezuela to be directly comparable to 2018 values. See Schedule A -

"Reconciliation of Non-GAAP Financial Measures" for a detailed

reconciliation of currency adjusted diluted EPS to diluted EPS

calculated in accordance with GAAP and a discussion of why the Company

believes this non-GAAP measure is useful.

With respect to guidance, the Company cannot accurately predict the

impact to its share base from any future share repurchases in 2018 and